In order to clarify the effect
Atrial natriuretic peptides (ANP) are hormones identified in the atria of animals (Currie et al., 1984) and man (Seidman et al., 1984) . It is capable of inducing diuresis (deBald, 1982) , natriuresis (Borenstein et al., 1983) , and smooth muscle relaxation and vasodilation (Currie et al., 1983) . These characteristics are similar to that of hyperthyroidism which is known to be characterized by natriuresis (Bell et al., 1982) and vasodilation (Degroot and Leonard, 1970) .
It has been earlier reported that the plasma ANP concentration increased in hyperthyroid rats (Kohno et al., 1986; Landenson et al., 1986 ) and hyperthyroid man (Kohno et al., 1987; Woolf and Moult, 1987) . Opposite results in man were then reported by Landenson et al. (1987) . We conjectured that these discrepancies were due to two main factors: the amount of dietary sodium intake and the method of measurring ANP. Sagnella et al.(1987) repoted that the plasma ANP concentration rises with increased dietary sodium intake. And we observed first hand the direct correlation between dietary sodium intake and the urinary sodium concentration which ranged from 30 to 500 mEq/g creatinine in outpatients to our clinic. We therefore felt the necessity to regulate dietary sodium in patients with Graves' disease where the effect of thyroid hormone plays heavily on the ANP concentration.
We also developed a sensitive RIA measurement with monoclonal antibody to alpha ANP (Naomi et al., 1987; Naomi et al., 1988) . In this manner we were able to study the effect of thyroid hormone, on the plasma ANP concentration measured by this new sensitive method, in Graves' disease when dietary sodium intake was constant.
Patients and Methods
After receiving informed consent, 14 patient with Graves' hyperthyroidism (4 males and 10 females, aged 34.1+12.3 years) were admitted to Noguchi Thyroid Clinic and Hospital Foundation for surgical treatment and study. No patient had taken any antithyroid drugs before admission.
After admission, methyl-mercaptoimidazole (MMI) 30 mg daily was administered for about one month until the time of surgery. A pre-operative study was carried out within one week of admission. All patients were in a hyperthyroid state in spite of pre-operative MMI therapy.
This was most likely due to the short duration of drug administration. Grave's disease was the primary diagnosis in all.
None showed signs of heart failure, and up to 8.3+3.5 fmol/ml on the fifth day of the high sodium diet (342 mEq/ day). There was a significant correlation between plasma ANP and serum FT4 (r= 0.52, p<0.02) and FT3 (r=0.47, p<0.05). However, no significant relationship was found between plasma ANP and systolic blood pressure, diastolic pressure and, pulse rate, cardio-thoracic ratio (CTR) and age.
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(Hyperthyroid) (Euthyroid) Fig. 1 . Plasma ANP concentration before and one week after surgery under a constant dietary sodium intake (171 mEq/ day) in 14 patients with Graves' disease. Note that the preoperative ANP concentration was significantly reduced after surgery when patients become euthyroid. As shown in Figure 1 , plsma ANP significatly decreased after surgery. The preoperation plasma ANP concentration in 14 Graves' disease patients was hiher than in the 6 normal controls when both groups were on a constant diet of 171 mEq/day sodium for five days. Table 1 . shows clinical and laboratory profiles before and one week after surgery in the 14 Graves' disease patients. Pre-operative plasma ANP, systolic blood pressure, heart rate, sodium output, FT3 and FT4 signicantly decreased after surgery, while creatinine output, urine volume and TSH were unchanged.
Discussion
The administration of thyroid hormone increased the amount of plasma ANP in rats (Kohno et al., 1986) . Matsubara et al.(1987) reported that thyroid hormone directly stimulates the synthesis of ANP by rat atrial myocytes, Moreover, Gardner et al.(1987) demonstrated that T3 administration induced both increased ANP release and increased m-RNA in an in vitro neonatal cardiomyocyte system. This explains how increased plasma ANP in hyperthyroid rats was attributed to the direct effect of thyroid hormone on cardiomyocytes. 
